Champlain Investment Partners, LLC Repligen Corp Transaction History

Champlain Investment Partners, LLC

$13.5 Billion
Q2 2025

A detailed history of Champlain Investment Partners, LLC transactions in Repligen Corp stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 1,401,088 shares of RGEN stock, worth $208 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

1,401,088

Previous 1,463,995 4.3%

Holding current value

$208 Million

Previous $186 Million 6.45%

% of portfolio

1.29%

Previous 1.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$108.89 - $145.23 $6.85 Million - $9.14 Million	-62,907 Reduced 4.3%	1,401,088 $174 Million
Q1 2025 May 14, 2025	SELL	$127.24 - $174.24 $10.1 Million - $13.9 Million	-79,535 Reduced 5.15%	1,463,995 $186 Million
Q4 2024 Feb 13, 2025	BUY	$123.41 - $160.92 $15.1 Million - $19.7 Million	122,595 Added 8.63%	1,543,530 $222 Million
Q3 2024 Nov 12, 2024	BUY	$119.79 - $167.35 $102 Million - $142 Million	850,345 Added 149.03%	1,420,935 $211 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $528,600 - $805,894	-4,405 Reduced 0.77%	570,590 $71.9 Million
Q1 2024 May 13, 2024	SELL	$170.78 - $208.42 $60 Million - $73.2 Million	-351,445 Reduced 37.93%	574,995 $106 Million
Q4 2023 Feb 13, 2024	BUY	$114.17 - $185.35 $8.13 Million - $13.2 Million	71,250 Added 8.33%	926,440 $167 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $33.9 Million - $43.1 Million	244,445 Added 40.02%	855,190 $136 Million
Q2 2023 Aug 11, 2023	BUY	$138.42 - $180.31 $7.57 Million - $9.87 Million	54,715 Added 9.84%	610,745 $86.4 Million
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $32.2 Million - $41.3 Million	208,630 Added 60.05%	556,030 $93.6 Million
Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $20.9 Million - $28.4 Million	128,665 Added 58.82%	347,400 $58.8 Million
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $35.1 Million - $56 Million	218,735 New	218,735 $40.9 Million

Others Institutions Holding RGEN

# of Institutions

504

Shares Held

58.7M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.25B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Champlain Investment Partners, LLC with notifications on news.

Account

Champlain Investment Partners, LLC Repligen Corp Transaction History